This report presents summary data for TB cases reported to the Division of TB Elimination (DTBE), verified, and counted in 2007. These reports of TB cases were submitted by 60 reporting areas (50 states, the District of Columbia, New York City, Puerto Rico, and seven other jurisdictions in the Pacific and Caribbean).
The video educates viewers on ways to effectively manage active TB. The animation includes information on preventing the spread of TB through TB testing, diagnosis, and treatment.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
This 60-minute webinar reviews best practices for TB diagnosis and management for ICE detainees, the role of public health and community partners, and how care is coordinated for patients who are released.
This pamphlet is the introduction to a series of TB-specific cultural competency guides for the birth countries most commonly reported by foreign-born persons being treated for TB in the United States.
This monograph provides information for use by tribal, state, and local public health practitioners and their legal counsel to help improve their understanding and use of relevant laws to respond to challenges concerning TB control. Part I of the monograph contains an introduction and table listing resources on communicable disease and TB control methods in selected US jurisdictions. Part II presents a brief overview of some of the essential components of TB control, including a discussion of the international and national threats of the disease and modern public health interventions.
This report is the annual compilation of data from World Health Organization’s (WHO) 193 member states. It provides a summary of the current status of national health and health systems, including mortality and burden of disease, causes of death, reported infectious diseases, health service coverage, risk factors, health systems resources, health expenditures, inequities, and demographic and socioeconomic statistics.
This report describes the investigation by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), which initially identified five confirmed cases of multidrug-resistant tuberculosis (MDR TB) in two distinct clusters, characterized by two distinct geographic locations, genotypes, and drug-susceptibility patterns in the Federated States of Micronesia. Extensive transmission had occurred among household contacts; 16 (8%) of the 205 contacts identified had confirmed or suspected MDR TB disease, and 124 (60%) had latent TB infection.
This report describes the investigation of a genotype cluster of eight tuberculosis cases in US born patients in the Detroit metropolitan area. The investigation was done by the Detroit Department of Health and Wellness Promotion, the Michigan Department of Community Health, and the Centers for Disease Control and Prevention. The first case was reported in a patient with drug-susceptible TB, who subsequently developed multidrug-resistant TB (MDR TB). Seven additional cases were reported in patients with TB genotypes matching that of the index patient.
This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control officials. The panel was convened by CDC and the Association of Public Health Laboratories (APHL) and in consultation with the Advisory Council for the Elimination of TB (ACET).
